Breast cancer that has spread beyond the breast, called metastatic breast cancer, often announces itself through new symptoms in specific parts of the body. The four most common sites where breast cancer spreads are the bones, liver, lungs, and brain. Each location produces distinct warning signs, and doctors use a combination of imaging, blood work, and tissue sampling to confirm whether cancer has reached a new site.
Some people discover metastatic disease through routine follow-up scans after an earlier breast cancer diagnosis. Others notice new, persistent symptoms that don’t have an obvious explanation. Knowing what to watch for, and understanding how doctors investigate these signs, can help you act quickly if something changes.
Signs of Spread to the Bones
Bone is the single most common destination for metastatic breast cancer cells. The hallmark symptom is bone pain that doesn’t go away, often worse at night or with activity, and located in areas like the spine, pelvis, ribs, or upper legs. This pain feels different from a pulled muscle or arthritis flare because it tends to be constant, progressive, and not relieved by rest or over-the-counter painkillers.
When cancer weakens bone, fractures can happen with minimal force or no injury at all. These are called pathologic fractures, and they sometimes reveal metastatic disease before any other symptom appears. Bone metastases can also release excess calcium into the bloodstream, a condition that causes nausea, vomiting, constipation, confusion, and excessive thirst.
If the spread is in the spine, it can press on the spinal cord. Warning signs of spinal cord compression include new pain or stiffness in the neck or back, sudden difficulty controlling your bladder or bowels, and weakness or numbness in the legs. This is a medical emergency that requires immediate attention to prevent permanent nerve damage.
Signs of Spread to the Liver
Liver metastases often develop silently at first. As cancer grows within the liver, you may notice a dull ache or feeling of fullness on the right side of your abdomen, just below your ribs. Swelling in the belly from fluid buildup is another common sign. Jaundice, a yellowing of the skin and whites of the eyes, occurs when tumors block bile flow and is one of the more recognizable indicators of liver involvement.
Appetite loss and unintentional weight loss frequently accompany liver spread. Some people also experience itchy skin or notice their urine has turned darker than usual. Liver function blood tests may show abnormalities before any physical symptoms appear, which is one reason oncologists monitor these values during follow-up care.
Signs of Spread to the Lungs
When breast cancer reaches the lungs, the most common early symptom is shortness of breath, particularly with activities that previously felt easy. A persistent dry cough that doesn’t respond to typical cold or allergy treatments can also signal lung involvement. Some people experience chest pain, though this is less common early on.
Fluid can accumulate between the lung and chest wall, a condition called pleural effusion, which makes breathing feel increasingly difficult. This fluid buildup sometimes develops before a tumor is visible on a standard chest X-ray.
Signs of Spread to the Brain
Brain metastases produce neurological symptoms that vary depending on which part of the brain is affected. Persistent headaches that feel different from your usual pattern, especially ones that are worse in the morning or accompanied by nausea, are a key warning sign. Seizures in someone with no prior seizure history are another red flag.
Other indicators include vision changes, difficulty speaking or finding words, confusion, personality shifts, weakness on one side of the body, and loss of balance. These symptoms develop because growing tumors put pressure on surrounding brain tissue. They can appear suddenly or build gradually over weeks.
General Symptoms That Suggest Spread
Some signs of metastatic breast cancer aren’t tied to a specific organ. Persistent, crushing fatigue that doesn’t improve with rest is one of the most frequently reported symptoms. Unexplained weight loss and a noticeable drop in appetite can signal that cancer is active somewhere in the body, even before a specific site is identified.
Swelling or a lump under your arm, near your collarbone, or along your breastbone may indicate cancer has reached nearby lymph nodes. Swelling in your arm or hand on the same side as a previous breast cancer can also be a sign of lymph node involvement rather than simple lymphedema from earlier treatment.
How Doctors Confirm Spread
Symptoms alone can’t confirm metastasis. Doctors rely on imaging tests, and sometimes a biopsy, to make a definitive diagnosis.
Imaging Tests
Bone scans are one of the most widely used tools for detecting skeletal metastases. They work by tracking areas of abnormal bone activity and are effective at surveying the entire skeleton in one session. CT scans of the chest, abdomen, and pelvis provide detailed images of the lungs, liver, and other soft tissue organs. CT is highly specific for bone lesions as well, correctly identifying them about 95% of the time, though it can miss some early changes.
PET-CT scans combine metabolic and anatomical imaging, and there is growing evidence they detect distant metastases with higher sensitivity than conventional imaging alone. Doctors often turn to PET-CT when standard scans produce uncertain or conflicting results. MRI is particularly useful for evaluating brain metastases and for getting a detailed look at bone marrow involvement. No single test is universally recommended over the others; doctors choose based on your symptoms and clinical situation.
Biopsy of the New Site
When imaging reveals a suspicious area, doctors typically want a tissue sample from the new site. This step matters for two reasons. First, it confirms that the growth is actually metastatic breast cancer and not an unrelated condition or a different type of cancer entirely. Second, cancer can change its biological profile as it spreads. Research shows that hormone receptor status differs between the original breast tumor and the metastatic site in about 20% of cases for estrogen receptors and 33% for progesterone receptors. The receptor that determines eligibility for targeted therapy (HER2) changes roughly 8% of the time.
These shifts directly affect which treatments will work. A tumor that was hormone-receptor positive in the breast may no longer respond to hormone therapy at the metastatic site. Biopsying the new location allows your oncology team to tailor treatment to the cancer you actually have now, not the cancer you had at your original diagnosis.
The Role of Blood Tests
Blood work plays a supporting role in detecting and monitoring spread. Certain tumor markers, including CA 15-3, CA 27-29, and CEA, can be elevated when breast cancer is active in the body. However, these markers have low sensitivity in early-stage disease and are not reliable enough to use as standalone screening or diagnostic tools. Major oncology guidelines in both the U.S. and Europe do not recommend using tumor markers alone to screen for recurrence or to monitor treatment response.
Where these markers become more useful is in advanced disease, particularly when cancer has spread to areas that are difficult to measure on imaging. Rising marker levels over time can signal that treatment isn’t working, prompting a change in approach. They are one piece of the puzzle, not the whole picture. Liver function tests and calcium levels can also provide indirect clues, sometimes flagging liver or bone involvement before symptoms become obvious.
When Spread Is Found With No Symptoms
It’s worth knowing that bone metastases and even liver or lung metastases sometimes cause no symptoms at all in their early stages. Some cases are discovered incidentally during imaging ordered for another reason, or through routine blood work that shows an unexpected abnormality. This is part of why follow-up care after a breast cancer diagnosis includes periodic monitoring, even when you feel well. The specific schedule and types of tests depend on the characteristics of your original cancer, including its stage, grade, and receptor status.